Literature DB >> 6863281

Inhibition by tosyl-L-phenylalanyl chloromethyl ketone of membrane potential changes in rat neutrophils. Correlation with the inhibition of biological activity.

R E Duque, S H Phan, M C Sulavik, P A Ward.   

Abstract

A plasma membrane-associated serine esterase (protease) has previously been reported to be required during stimulation of a variety of cell types. In this study we have examined the role of such a protease on membrane potential changes using an optical probe of membrane potential 3,3'-dipropylthiodicarbocyanine iodide. The irreversible chymotrypsin-like protease inhibitor TPCK (tosyl-L-phenylalanyl chloromethyl ketone) inhibited membrane potential changes in rat neutrophils in response to phorbol myristate acetate, N-formylmethionylleucylphenylalanine and the calcium ionophore A23187 in a time- and dose-dependent manner. This inhibition was correlated with the known inhibitory effects on superoxide (O-2) generation and enzyme release (lysozyme and beta-glucuronidase). High external calcium concentrations overcame the inhibitory effects of TPCK on A23187-induced stimulation but had no effect on the inhibition of N-formylmethionylleucylphenylalanine stimulation. These results suggest that a TPCK-inhibitable activity is required for the development of the membrane potential changes that are coupled to subsequent secretory events and precede a calcium requiring activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6863281

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Another biological effect of tosylphenylalanylchloromethane (TPCK): it prevents p47phox phosphorylation and translocation upon neutrophil stimulation.

Authors:  Maggaly Gillibert; Zakia Dehry; Micheline Terrier; Jamel El Benna; Florence Lederer
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

2.  Requirement for cell-bound proteases in the mechanism of human neutrophil activation with various stimuli.

Authors:  R J Smith; S C Speziale; L M Sam; J M Justen; B J Bowman
Journal:  Inflammation       Date:  1986-09       Impact factor: 4.092

3.  Influence of the anti-inflammatory serine esterase inhibitor gabexate mesilate (Foy) on aggregation, locomotion and adhesion of polymorphonuclear leukocytes.

Authors:  B Damerau; H Wüstefeld; D Fricke; H Kunze
Journal:  Agents Actions       Date:  1984-12

4.  Monoclonal antibody characterization of a chymotrypsin-like molecule on neutrophil membrane associated with cellular activation.

Authors:  C H King; C H Goralnik; P J Kleinhenz; J A Marino; J R Sedor; A A Mahmoud
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

5.  Functional defects in phagocytic cells following thermal injury. Application of flow cytometric analysis.

Authors:  R E Duque; S H Phan; J L Hudson; G O Till; P A Ward
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307

6.  Inhibition of neutrophil activation by p-bromophenacyl bromide and its effects on phospholipase A2.

Authors:  R E Duque; J C Fantone; C Kramer; W A Marasco; S H Phan
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

7.  Differential sensitivity of anti-IgM-induced and NaF-induced inositol phospholipid metabolism to serine protease inhibitors in BAL17 B lymphoma cells.

Authors:  J Mizuguchi; N Utsunomiya; M Nakanishi; Y Arata; H Fukazawa
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

8.  Inhibition of neutrophil chemotaxis by protease inhibitors. Differential effect of inhibitors of serine and thiol proteases.

Authors:  J B Barna; R R Kew
Journal:  Inflammation       Date:  1995-10       Impact factor: 4.092

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.